Enveric Biosciences (ENVB) vs NeuroSense Therapeutics (NRSN)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
NeuroSense Therapeutics is the larger company by market cap ($6.8 million vs $6.8 million), about 1.0 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Head-to-head
| Metric | ENVB | NRSN |
|---|---|---|
| Share price | $1.51 | $3.58 |
| Market cap | $6.76M | $6.79M |
| 1-day change | +1.00% | -6.03% |
| EPS (TTM) | $-13.01 | $-47.10 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $13.25 | $26.64 |
| 52-week low | $1.17 | $3.56 |
| Distance from 52-week high | -88.60% | -86.56% |
| Average volume | 103.09K | 21.08K |
| Shares outstanding | 4.48M | 1.90M |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
ENVB vs NRSN FAQ
Which is bigger, Enveric Biosciences or NeuroSense Therapeutics?
NeuroSense Therapeutics (NRSN) is larger, with a market capitalization of $6.79M compared with $6.76M for Enveric Biosciences (ENVB).
Are Enveric Biosciences and NeuroSense Therapeutics in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.